Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,671,471
-
Share change
-
-2,222,520
-
Total reported value
-
$9,476,016
-
Put/Call ratio
-
114%
-
Price per share
-
$2.03
-
Number of holders
-
43
-
Value change
-
-$11,188,478
-
Number of buys
-
19
-
Number of sells
-
30
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q4 2017
As of 31 Dec 2017 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,671,471 shares of stock of the company.
Largest 10 holders included Vanguard Group Inc, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Geller Family Office Services, LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, A.R.T. Advisors, LLC, and NATIXIS.
This table shows 43 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.